FAS and neuroblastoma: There is compelling evidence demonstrating that reduced expression of FAS and/or increased expression of FASL have been detected in many types of human cancer including NB, indicating the aberrant expression of FAS/FASL system might act as a mechanism for tumor cells to escape from the host immune system [19], [20].